Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
Data
2020Autor
Goodarzi, Pedram
Mahdavi, Farzad
Mirzaei, Rasoul
Hasanvand, Hamze
Sholeh, Mohammad
Zamani, Farhad
Sohrabi, Masodreza
Tabibzadeh, Alireza
Salimi Jeda, Ali
Karbalaie Niya, Mohammad Hadi
Keyvani, Hossein
Karampoor, Sajad
Metadata
Mostrar registro completo
Documentos PDF
Imagenes y Videos
Resumo
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads rapidly worldwide. No
proven effective therapies currently exist for this virus, and efforts to develop antiviral strategies for the
treatment of COVID-19 are underway. The rapidly increasing understanding of SARS-CoV-2 virology provides a
notable number of possible immunological procedures and drug targets. However, gaps remain in our understanding of the pathogenesis of COVID-19. In this review, we describe the latest information in the context of
immunological approaches and emerging current antiviral strategies for COVID-19 treatment.
Palabras clave
SARS-CoV-2; COVID-19; Drug targets; Antiviral strategies; Immunological approachesLink para o recurso
https://doi.org/10.1016/j.intimp.2020.106885Collections
Estadísticas Google Analytics
Comments
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.